Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 21, 2023
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
[ Tue, Feb 21st 2023
] - WOPRAI
Balaji Prasad Maintained (ZTS) at Buy with Increased Target to $260 on, Feb 21st, 2023
Balaji Prasad of Barclays, Maintained "Zoetis Inc." (ZTS) at Buy with Increased Target from $250 to $260 on, Feb 21st, 2023.
Balaji has made no other calls on ZTS in the last 4 months.
There are 3 other peers that have a rating on ZTS. Out of the 3 peers that are also analyzing ZTS, 0 agree with Balaji's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Balaji
- Erin Wright of "Morgan Stanley" Maintained at Buy with Decreased Target to $248 on, Tuesday, November 15th, 2022
- Michael Ryskin of "B of A Securities" Maintained at Strong Buy with Decreased Target to $180 on, Friday, November 4th, 2022
- Nathan Rich of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $180 on, Friday, November 4th, 2022
